6,382 articles
A new 45-item standardized protocol aims to close the gap in sideline concussion evaluation during live football matches worldwide.
Harvard's COMPASS model forecasts which patients will respond to immune checkpoint inhibitors with striking accuracy across seven cancer types.
A Nature Medicine commentary reviews the accelerating pipeline of Lassa fever countermeasures, signaling progress against a deadly viral hemorrhagic disease.
A newly discovered enzyme-driven feedback cycle helps liver tumors suppress immunity and resist checkpoint blockade — and blocking it may help.
A brain-penetrant compound targets a key region of TDP-43, reducing motor neuron loss and extending survival in ALS mouse models.
A multi-omic study finds trained older adults retain muscle molecular profiles resembling those of young adults, revealing exercise's deep anti-aging effects.
A comprehensive review reveals how gut bacteria harbor, spread, and amplify antibiotic resistance genes—and outlines emerging strategies to fight back.
A 2025 review maps how gut bacteria and their metabolites protect against radiotherapy damage—and how microbial therapies could transform cancer treatment.
A 2025 review reframes dietary protein quality as a multifaceted metric—digestibility, EAA density, and bioavailability—with major implications for aging adults.
A new stepwise feeding framework aligns nutrition delivery with three metabolic phases of critical illness, challenging one-size-fits-all ICU feeding.
A landmark study across US and UK populations identifies gut microbiome species consistently tied to cardiometabolic risk, diet quality, and disease markers.
Mesenchymal stem cells modulate immunity and reduce kidney damage in lupus nephritis, with clinical trials showing real but inconsistent gains.
